What's new

Orphan designation: defibrotide Prevention of hepatic veno-occlusive disease, 29/07/2004 Withdrawn

Orphan designation: defibrotide Prevention of hepatic veno-occlusive disease, 29/07/2004 Withdrawn

Jun 5, 2025 - 15:00
 0
Orphan designation: defibrotide Prevention of hepatic veno-occlusive disease, 29/07/2004 Withdrawn
Orphan designation: defibrotide Prevention of hepatic veno-occlusive disease, 29/07/2004 Withdrawn
Read More

Tags:

Previous Article

Highlights - Second EMA / Alliance for Regenerative Medicine bilateral meeting

Next Article

Orphan designation: defibrotide Prevention of graft-versus-host disease, 13/11/2...

Related Posts

Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Date of authorisation: 02/05/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0

Confidentiality undertaking for observers

May 16, 2025  0

Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Date of authorisation: 26/09/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0